Skip to content
Home » Vaccines » BCG vaccine

BCG vaccine

bcg vaccine alzheimer's disease

BCG vaccine may be a weapon against Alzheimer’s disease

New research suggests the century-old BCG tuberculosis vaccine may also reduce Alzheimer’s disease risk. Originally developed against TB by Calmette and Guérin and proven highly effective, this vaccine now appears to have broad immunotherapeutic benefits. Clinical trials have demonstrated its potential in lowering Alzheimer’s and dementia risks, with studies indicating a 20-45% decrease in older patients with bladder cancer. Studies call for more research to validate these promising results, given Alzheimer’s growing prevalence and economic impact.

bcg vaccine liver cancer

100-year-old BCG vaccine — promising treatment for liver cancer

The BCG vaccine, initially for tuberculosis, shows promise in treating hepatocellular carcinoma (HCC), common liver cancer, as per a study by UC Davis researchers. The vaccine, in animal models, triggered an immune response reducing cancer growth. With its history of repurposing for bladder cancer and potential in diabetes reversal, this FDA-approved vaccine may soon enter clinical trials for HCC.